The recent call by U.S. scientists for a temporary pause "in the application of germ-line modification for clinical application in humans while the implications of such activity are discussed" has added a new intensity to the debate and reveals a potential bioethical divide between the US and the UK.
More than once in China, under a gloaming pall of poisonously polluted air I have watched oceans of people flood the streets and shops of Beijing or Chengdu or Guangzhou acquiring the material goods that they hope might improve their lives, and thought to myself "We're screwed. The earth just can't handle this."
There's nothing inspiring or empowering about two male CEOs taking credit for a young woman's work while twisting the entire purpose from being about reproductive health to being little more than a joke. But a 20-year-old ultrafeminist scientist who's about to launch her own company? That will be something to watch.
The stem-cell disgrace of Korean cloning fraudster Hwang Woo-suk has now inspired a movie. Whistle Blower opened in Korea this week. Names have been changed, and it's presented as fiction, but no one is even pretending it's not about the scientific "scandal of the century" that unfolded between 2004 and 2006.